Menu
SOPHiA GENETICS™ is thrilled to return for ACMG 2025! Visit us at booth #322 to learn more about our SOPHiA DDM™ and Alamut™ Visual plus platforms for rare and inherited diseases. Stay tuned for more information on our Exhibit Theatre presentation.
SOPHiA GENETICS™ thrilled to be back at ESHG 2025! Come meet our team to learn how SOPHiA GENETICS can help turn complex generic data into life-changing Insights!
SOPHiA GENETICS™ is thrilled to return for Festival of Genomics! Visit us at booth #91 to learn more about the New Generation SOPHiA DDM™ Platform and Alamut™ Visual Plus.
[et_pb_section fb_built="1" theme_builder_area="post_content" _builder_version="4.24.2" _module_preset="default"][et_pb_row _builder_version="4.24.2" _module_preset="default" theme_builder_area="post_content"][et_pb_column _builder_version="4.24.2" _module_preset="default" type="4_4" theme_builder_area="post_content"][et_pb_text _builder_version="4.24.2" _module_preset="default" theme_builder_area="post_content" hover_enabled="0" sticky_enabled="0"]At SOPHiA GENETICS, we collaborate with genetic experts to develop specialized next-generation sequencing (NGS) applications that seamlessly integrate into any laboratory workflow. In this Webinar our partners share how the analytical technology and dedicated features in the SOPHiA DDM™️ Platform have enabled the accurate detection and streamlined assessment of variants associated with Rare Diseases and Pharmacogenomics.
Discover how the SOPHiA DDM™️ Platform seamlessly integrated into routine NGS workflows for Pharmacogenetic analysis.
This talk took place at on June 11th in Glasgow, UK at the European Society of Human Genetics (ESHG) Conference 2023.
Featured Presenter:
[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row _builder_version="4.24.2" _module_preset="default" theme_builder_area="post_content" column_structure="1_3,2_3"][et_pb_column _builder_version="4.24.2" _module_preset="default" type="1_3" theme_builder_area="post_content"][et_pb_image src="https://www.sophiagenetics.com/wp-content/uploads/2024/03/Picture-1.jpg" _builder_version="4.24.2" _module_preset="default" theme_builder_area="post_content" title_text="Picture 1" hover_enabled="0" sticky_enabled="0"][/et_pb_image][/et_pb_column][et_pb_column _builder_version="4.24.2" _module_preset="default" type="2_3" theme_builder_area="post_content"][et_pb_text _builder_version="4.24.2" _module_preset="default" theme_builder_area="post_content" hover_enabled="0" sticky_enabled="0"]Robert C. Akkers
Molecular Biologist at Result Laboratorium, Dordrecht, Netherlands
After my PhD at the department for Molecular Biology in Nijmegen, I continued my career as an application specialist genomics (NGS). During this work I got really enthusiastic about the field of molecular diagnostics. After a nice postdoc position at the Department of Genetics in Wageningen I got the chance to pursue my true passion and became a molecular biologist at Result Laboratorium (Clinical Chemistry) and the Department for Pathology in Dordrecht. Besides my role in routine diagnostics I enjoy implementing new techniques and new panels for molecular diagnostics.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]A major challenge in precision medicine is quick, reliable identification of potentially disease-causing genetic variants.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at support@sophiagenetics.com to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.